Exploratory Study on the Effects of Early Rosuvastatin Treatment in Patients With Acute Ischemic Stroke
Status:
Unknown status
Trial end date:
2017-07-01
Target enrollment:
Participant gender:
Summary
This is an exploratory, randomized, open-label, 2-arm, parallel-group study exploring the
efficacy of rosuvastatin (20mg/day) in patients with acute ischemic stroke.